Evercore ISI analyst Vijay Kumar notes Agilent’s (A) stock faced pressure before earnings, largely due to weakness in the life science tools group, and says the second quarter was “stable,” with Agilent reiterating its guidance. The firm sees “mixed signals” post-earnings, but “some strengths shine through,” noting that the stock is being removed from the firm’s “Tactical Outperform” list after earnings. The firm has an In Line rating and $125 price target on Agilent shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on A:
- Agilent Technologies Reports Strong Q2 Earnings Amid Market Challenges
- Early notable gainers among liquid option names on May 29th
- Agilent price target lowered to $130 from $150 at UBS
- Agilent’s Strong Performance and Promising Outlook: A Buy Recommendation by Daniel Arias
- Agilent price target lowered to $155 from $160 at JPMorgan